In the peri-infarct cortex 21 days after stroke (18 days after the first delivery of BMSCs), there was a significant increase in NeuN/BrdU co-labeled cells (Fig. 5C, D) and Glut-1/BrdU co-labeled cells (Fig. 5E, F) compared to vehicle-treated stroke controls. This evidence concerns the gene SLC2A1 and Stroke.